Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on June 16, 2025
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
GlobeNewswire
·
June 16, 2025
BEDFORD, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit …
Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
GlobeNewswire
·
June 16, 2025
Three Phase 1 studies support once-daily inhaled administration of mosliciguat with no evidence of serious systemic side effects Results informed the ongoing Phase 2 PHocus study of mosliciguat for the treatment of pulmonary hypertension associated with …
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire
·
June 16, 2025
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19 …
Mavenir Signs Debt Recapitalization Transaction to Drive Continued Growth
GlobeNewswire
·
June 16, 2025
Transaction to strengthen Mavenir’s balance sheet and support its strategic focus on its profitable Mobile Core segment Mavenir to refocus Open RAN investments on 4G and 5G software, will accelerate investment in AI Siris to be controlling shareholder with …
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
GlobeNewswire
·
June 16, 2025
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful …
Coda Octopus Group Reports Fiscal Second Quarter 2025 Financial Results
GlobeNewswire
·
June 16, 2025
ORLANDO, FL, June 16, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology for real-time subsea intelligence and cutting-edge diving technology, …
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
GlobeNewswire
·
June 16, 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia: FDA PDUFA goal date of August 15, 2025 TNX-102 SL demonstrated statistically significant improvement in the primary …
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
GlobeNewswire
·
June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, is proud to recognize Migraine and Headache Awareness Month …
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
GlobeNewswire
·
June 16, 2025
STILLWATER, Okla., June 16, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced it has signed a memorandum of understanding (MOU) with Moog Electric Motion Solutions (Moog) for delivery of the Company’s neo …
iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment
GlobeNewswire
·
June 16, 2025
iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates (NHP) and assess early signs of efficacy on fat reduction and body …
Abcourt recoupe 4,1 g/t d’or sur 11 mètres en rainure sur l’ancien décapage de Cambior, prolonge la zone minéralisée sur maintenant 300m de long dans le secteur Cartwright du projet Flordin et présente une mise à jour corporative
GlobeNewswire
·
June 16, 2025
ROUYN-NORANDA, Québec, 16 juin 2025 (GLOBE NEWSWIRE) -- Mines Abcourt Inc. (« Abcourt » ou la « Société ») (TSX Venture : ABI) (OTCQB : ABMBF) est heureuse d’annoncer ses plus récents résultats d’échantillonnage en rainure sur l’ancien décapage de Cambior …
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
GlobeNewswire
·
June 16, 2025
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001 On Track to Submit IND Application for CR-001 in Fourth Quarter of 2025 with Proof-of-Concept Clinical …
Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty
GlobeNewswire
·
June 16, 2025
Ampere Metals to acquire Virginia Project for a total consideration of US$ 8.0 million: US$5 million for the sale of the mineral rights and US$3 million for the sale of the landholdings over 5 years of scheduled payments Mirasol will retain a 2% NSR …
Abcourt Intersects 4.1 g/t Gold over 11 Metres in Channel on the Former Cambior Stripping, extends the mineralized zone over a length of now 300m in the Cartwright Area of the Flordin Project, and Presents a Corporate Update
GlobeNewswire
·
June 16, 2025
ROUYN-NORANDA, Quebec, June 16, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. ("Abcourt" or the "Company") (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce its most recent channel sampling results from the former Cambior stripping that was done in …
Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress
GlobeNewswire
·
June 16, 2025
ZUG, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …
VEON Announces USD 35 Million Share Buyback
GlobeNewswire
·
June 16, 2025
Announcement marks the third phase of USD 100 million share buyback program Dubai, June 16, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), announces that it will shortly commence the third phase of its previously …
Castellum Announces Closing of $5.0 Million Public Offering of Common Stock and Warrants
GlobeNewswire
·
June 16, 2025
VIENNA, Va., June 16, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced the closing of its …
Blue Moon Metals Completes First Blast on Nussir Access Portal Ahead of Schedule
GlobeNewswire
·
June 16, 2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce that the company has commenced underground construction on the Nussir Mine completing the first blast on the …
Exploring Changzhou's Life Aesthetics Along Grand Canal
GlobeNewswire
·
June 16, 2025
CHANGZHOU, China, June 16, 2025 (GLOBE NEWSWIRE) -- On June 10, the event "An Encounter with Chinese Culture: Jiangsu Week of the Grand Canal Culture" was held in Brussels, home to the headquarters of the European Union. With the Grand Canal as a symbolic …
Inflection Resources to Acquire Portfolio of Australian Copper-Gold Projects from Newmont Corporation
GlobeNewswire
·
June 16, 2025
VANCOUVER, British Columbia, June 16, 2025 (GLOBE NEWSWIRE) -- Inflection Resources Ltd. (CSE: AUCU / OTCQB: AUCUF / FSE: 5VJ) (the "Company" or "Inflection") is pleased to announce it has entered into definitive agreement dated June 13, 2025 to acquire an …